Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F19%3A00336576" target="_blank" >RIV/68407700:21460/19:00336576 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://doi.org/10.1109/EHB47216.2019.8969876" target="_blank" >https://doi.org/10.1109/EHB47216.2019.8969876</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1109/EHB47216.2019.8969876" target="_blank" >10.1109/EHB47216.2019.8969876</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden

  • Popis výsledku v původním jazyce

    According to IDF, the worldwide cost of treating diabetes mellitus (DM) in patients aged 20 to 79 years is estimated at 727 million USD. The aim of this study was to conduct a pilot investigation of the impact of prolonged use of the continuous glucose monitoring sensors on the measurement accuracy and on the costs associated with these sensors. Data from 10 patients with type I DM who used the CGM sensor for a prolonged period beyond the expiration date specified by the manufacturer were used for analysis and statistical processing. The Enlite and Dexcom sensors partially or fully covered by public health insurance in the Czech Republic were used. A total of 453 measurements were analyzed. Nonparametric statistic tests were used for statistical data processing. The study results shown that the prolongation of the sensor usage time does not have a significant influence on the accuracy of its measurement. At the same time, it was confirmed that there was a statistically significant difference between the values of glycemia measured by CGM and the blood glucose level measured by personal glucometer. The cost reduction of 30-85% could be achieved in case of prolonged use of CGM sensors (from 6-7 days to 10 days), depending on the sensor type and age group of the patient.

  • Název v anglickém jazyce

    The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden

  • Popis výsledku anglicky

    According to IDF, the worldwide cost of treating diabetes mellitus (DM) in patients aged 20 to 79 years is estimated at 727 million USD. The aim of this study was to conduct a pilot investigation of the impact of prolonged use of the continuous glucose monitoring sensors on the measurement accuracy and on the costs associated with these sensors. Data from 10 patients with type I DM who used the CGM sensor for a prolonged period beyond the expiration date specified by the manufacturer were used for analysis and statistical processing. The Enlite and Dexcom sensors partially or fully covered by public health insurance in the Czech Republic were used. A total of 453 measurements were analyzed. Nonparametric statistic tests were used for statistical data processing. The study results shown that the prolongation of the sensor usage time does not have a significant influence on the accuracy of its measurement. At the same time, it was confirmed that there was a statistically significant difference between the values of glycemia measured by CGM and the blood glucose level measured by personal glucometer. The cost reduction of 30-85% could be achieved in case of prolonged use of CGM sensors (from 6-7 days to 10 days), depending on the sensor type and age group of the patient.

Klasifikace

  • Druh

    D - Stať ve sborníku

  • CEP obor

  • OECD FORD obor

    20601 - Medical engineering

Návaznosti výsledku

  • Projekt

  • Návaznosti

    S - Specificky vyzkum na vysokych skolach

Ostatní

  • Rok uplatnění

    2019

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název statě ve sborníku

    IEEE E-HEALTH AND BIOENGINEERING EHB 2019

  • ISBN

    978-1-7281-2603-6

  • ISSN

  • e-ISSN

    2575-5145

  • Počet stran výsledku

    4

  • Strana od-do

  • Název nakladatele

    Gr. T. Popa University of Medicine and Pharmacy

  • Místo vydání

    Iasi

  • Místo konání akce

    Iasi

  • Datum konání akce

    21. 11. 2019

  • Typ akce podle státní příslušnosti

    WRD - Celosvětová akce

  • Kód UT WoS článku

    000558648300008